CR1 is associated with amyloid plaque burden and age-related cognitive decline.
about
A common polymorphism near PER1 and the timing of human behavioral rhythmsThe genetics and neuropathology of Alzheimer's diseaseLate-Onset Alzheimer's Disease Genes and the Potentially Implicated PathwaysInflammatory process in Alzheimer's DiseaseGenetic variants in Alzheimer disease - molecular and brain network approachesGenome-wide association study of the rate of cognitive decline in Alzheimer's disease.Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium.Genetic variation at CR1 increases risk of cerebral amyloid angiopathy.Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memoryAssociation and interaction effects of Alzheimer's disease-associated genes and lifestyle on cognitive aging in older adults in a Taiwanese population.Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease.Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci.Epigenomics of Alzheimer's disease.Low levels of cerebrospinal fluid complement 3 and factor H predict faster cognitive decline in mild cognitive impairment.Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's diseaseAssociations between inflammation and cognitive function in African Americans and European AmericansEpistatic genetic effects among Alzheimer's candidate genes.A kernel machine method for detecting effects of interaction between multidimensional variable sets: an imaging genetics application.FASTKD2 is associated with memory and hippocampal structure in older adults.A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology.Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast.Alzheimer's loci: epigenetic associations and interaction with genetic factors.The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease.A genome-wide scan for common variants affecting the rate of age-related cognitive decline.A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline.Overview and findings from the religious orders studyCommon variants at 12q14 and 12q24 are associated with hippocampal volume.Overview and findings from the rush Memory and Aging ProjectIdentification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients.Microglial malfunction: the third rail in the development of Alzheimer's disease.Alzheimer's Genetic Risk Intensifies Neurocognitive Slowing Associated with Diabetes in Non-Demented Older AdultsGWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.Alzheimer risk variant CLU and brain function during aging.Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changesEffect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotypeAnalysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk LociAlzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding.Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant.
P2860
Q24630975-FF86382A-27F6-43C5-ADE7-EEA6C58AA7ADQ26998097-78EE83A6-08ED-400E-91F4-7826F49365FAQ27014964-FEE737CD-4266-4211-B63D-B8C192C5A0E9Q27500412-D79A3D7C-07F8-4345-BD20-DCCACB04673EQ28596011-7F6BD803-6816-4880-A99D-618A03A879A1Q29416991-85674AD0-5573-4756-AD02-ED685BF96DE8Q30300864-7C0E1899-FEA9-49C4-9819-F845B36862E1Q30422717-81C029C9-78DF-401E-A63F-2F51DB08E56FQ30513966-E7895FA5-54B2-497C-B4A6-6FB283F90EB3Q33648361-0F219AF8-BD9A-465C-A7FF-0D557602C431Q33745617-A83FBA2C-77DA-4977-9E07-8826CAC48DA4Q34429308-0A8D1944-15BD-4DF0-A9EF-524F591D2BA2Q34433829-FE5DC265-ED12-4E61-81E3-6249C1F196FBQ34518584-B1CBDE58-C52E-4B33-ABB4-B3C75F749A95Q34630522-1FA13E7E-58E9-4B89-BE28-D6AEEC9E75A1Q34718358-A906B7B8-BD9D-4D3D-A4B5-2752DAA05D6AQ34729552-268F9E96-AC10-43E6-B8BA-922E689507AFQ35049287-21249BD5-92EB-4C9A-9B5A-1CB6C091436DQ35117929-ECF8A94A-ADFA-4496-B500-B2ADE4BA2AD1Q35593903-07D121B7-54D6-47AC-8E63-4D42CB34F07AQ35702861-1E598F7F-0E8F-4FFE-9BD1-59096A82896CQ35763361-1D5B5485-9D5B-4E55-AA43-6E35FA9159C7Q35777262-4E205334-8DCA-43C9-87BF-CA2EB110D78FQ35836521-19194182-BDD5-4D6C-9160-EB97B4CB727CQ35840292-A7610C2F-D69F-4445-8FE2-96954F809F6DQ35909452-D37C4561-FF8E-4C53-8B4E-7D0E43116540Q36130996-DB8410CF-581B-40B8-BCBD-EBE30E182855Q36189386-EB3A50B7-FD26-4EE6-8CA9-8B468DAB8851Q36226167-D0C75267-A2E8-42A9-9595-E5124A8274E8Q36346551-9272B54F-A46C-44F4-A4CF-DBD828C2D854Q36348184-A5DD432B-4D62-4DB5-938A-C49B82488349Q36350995-439FAC09-0888-451B-965E-85A2E41FE2F8Q36351585-A27BB744-B5F3-4C38-879E-E115E34A1569Q36368439-7E6B1127-4509-4A91-9569-51B1F94C22DCQ36438010-A4B57150-E186-479B-B5A9-67076DF20096Q36503998-E4A4FBB8-610E-4A53-B775-7107B3954DF9Q36620401-09A95A2C-8585-4D75-9253-AC5B40FA4EABQ36625970-D0637D43-788A-4C11-BC8C-D30766CC3014Q36733874-8D4183A4-4677-47CE-8593-830D68EC263AQ36765873-4E92C8ED-6142-4F4A-AD92-9574241451D7
P2860
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@ast
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@en
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@nl
type
label
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@ast
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@en
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@nl
prefLabel
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@ast
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@en
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@nl
P2093
P2860
P50
P356
P1433
P1476
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
@en
P2093
Amanda J Myers
Aron S Buchman
Christopher B Heward
Cristin Aubin
Denis A Evans
Jason J Corneveaux
Joshua M Shulman
Julie A Schneider
Lori B Chibnik
P2860
P304
P356
10.1002/ANA.22277
P577
2011-03-09T00:00:00Z